Franz König is invited panelist at FDA & SCT/ QSPI workshop

Franz König is one of the invited panelists at FDA & SCT/QSPI workshop on innovations in the science and practice of clinical trials in Washington today. The panel discussion is part of the session on Rare Diseases, Small Clinical Trials and Rare events. For further information see the sct website. The program of the workshop is provided here.